BiotechTube
TRIGA-S

TRIGA-S

Berlin, Germany· Est.
triga-s.de
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

TRIGA-S GmbH is a specialized, service-based CRO focused exclusively on the IVD sector, offering end-to-end support for performance studies required under the EU's IVDR. Its key assets include deep regulatory expertise, an in-house BSL2 laboratory, and a track record of managing over 500 study sites and 1 million samples globally. The company is well-positioned as a critical service provider for IVD manufacturers navigating the stringent and complex regulatory landscape in Europe and beyond, though its growth is tied to the broader IVD development pipeline and competitive CRO market.

DiagnosticsMedical Devices

Technology Platform

Integrated IVD CRO service platform featuring an in-house BSL2 laboratory for contract measurements, comprehensive sample management/storage, and full-service clinical operations and biostatistics capabilities, all geared toward compliance with IVDR and other regulatory standards.

Opportunities

The stringent EU IVDR creates a sustained, multi-year demand for specialized performance study services.
Growth in the global IVD market, especially in areas like oncology, infectious disease, and point-of-care testing, expands the potential client base.
Opportunities exist to offer new service lines like Post-Market Performance Follow-up (PMPF) studies and to expand geographically.

Risk Factors

Business is highly dependent on the stringent EU IVDR; regulatory changes could impact demand.
Faces competition from large global CROs and niche specialists.
Revenue is project-based and subject to the R&D spending cycles and funding health of IVD biotech clients.

Competitive Landscape

TRIGA-S competes in the IVD-focused CRO segment against larger, diversified global CROs (e.g., IQVIA, LabCorp, Parexel) that have IVD divisions, as well as other specialized European CROs. Its differentiation is its deep, exclusive focus on IVD, owned BSL2 lab, and tailored approach, but it must contend with the broader resources and global reach of larger players.

More companies in Diagnostics & Precision Medicine →More companies in Germany →